|
1. Bristol Myers' schizophrenia drug fails key study Full story
2. Medicaid plans often restrict diabetes therapies with heart benefits: Study Full story
3. What's driving stronger reimbursement strategies in '25? Find out — here.
4. 1st pediatric patient receives FDA-approved gene therapy Full story
5. Feds ask for new clinical trial for Novavax COVID-19 shot Full story
6. Hospital pharmacies face new pressures in 2025 — Find strategies to navigate them, here.
7. Pharma tariffs would raise drug costs by $51B: Report Full story
8. Drug approvals to watch in 2025 Full story
Becker's Learning Opportunities
9. Missed the ERC deadline? Tax experts share advice for late filers here.
10. Reactive denial management isn't enough. How hospitals can shift to prevention for ROI: here.
11. The shift that solved staffing imbalances at Lee Health Cancer Institute: Here.
|
.png)
